(Q35709754)

English

Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Jacob Abarca

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Daniel C Malone

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Edward P Armstrong

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Woodie M Zachry

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

351-357

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

beta-blocker therapy: a standard of care for heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Race, quality of care, and outcomes of elderly patients hospitalized with heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

A chronic disease score from automated pharmacy data

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

The use of claims databases for outcomes research: rationale, challenges, and strategies

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

A new casemix adjustment index for hospital mortality among patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.351.33175

21 January 2018

Identifiers

10.1592/PHCO.24.4.351.33175

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35709754&oldid=1584267190"